Page last updated: 2024-08-24

telmisartan and Lung Neoplasms

telmisartan has been researched along with Lung Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (77.78)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Arthur, P; Gebeyehu, A; Kalvala, AK; Mondal, A; Nottingham, E; Patel, N; Rishi, AK; Singh, M; Surapaneni, SK	1
Banerjee, J; Bharadwaj, S; Foran, E; Green, R; Howell, M; Katiri, S; Khalil, R; Mohapatra, S; Mohapatra, SS; Nair, R; Singh, M; Yan, J	1
Arthur, P; Bagde, A; Gebeyehu, A; Kutlehria, S; Mondal, A; Nottingham, E; Patel, N; Singh, M; Surapaneni, SK	1
Lee, JH; Moon, JH; Nazim, UM; Park, SY; Rasheduzzaman, M	1
Doddapaneni, R; Godugu, C; Jackson, T; Marepally, S; Patel, AR; Singh, M	1
Chen, L; Li, J; Liu, B; Yang, Y; Yu, P; Zhu, J	1
Behl, G; Boakye, CH; Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M	1
Azoulay, L; Bartels, DB; Dell'Aniello, S; Suissa, S; Tascilar, K	1
Debanne, SM; Fang, JC; Rowland, DY; Simon, DI; Sipahi, I	1

Reviews

1 review(s) available for telmisartan and Lung Neoplasms

Article	Year
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. The Lancet. Oncology, 2010, Volume: 11, Issue:7 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan	2010

Article

Year

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.

The Lancet. Oncology, 2010, Volume: 11, Issue:7

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan

2010

Other Studies

8 other study(ies) available for telmisartan and Lung Neoplasms

Article	Year
Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer. Anticancer research, 2021, Volume: 41, Issue:9 Topics: Acrylamides; Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Pyrimidines; Sorafenib; Spheroids, Cellular; Spiro Compounds; Telmisartan; Thiadiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2021
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway. Scientific reports, 2019, 12-03, Volume: 9, Issue:1 Topics: Animals; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Signal Transduction; Telmisartan; Wnt Signaling Pathway	2019
Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts. Toxicology and applied pharmacology, 2020, 08-15, Volume: 401 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Telmisartan; Xenograft Model Antitumor Assays	2020
Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux. The international journal of biochemistry & cell biology, 2018, Volume: 102 Topics: A549 Cells; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Humans; Lung Neoplasms; Molecular Targeted Therapy; Phosphorylation; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Telmisartan; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation	2018
Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models. Journal of controlled release : official journal of the Controlled Release Society, 2013, Nov-28, Volume: 172, Issue:1 Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Collagen; Female; Humans; Losartan; Lung; Lung Neoplasms; Mice; Nanoparticles; Telmisartan	2013
Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells. Molecules (Basel, Switzerland), 2014, Mar-05, Volume: 19, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Matrix Metalloproteinase 9; PPAR gamma; RNA, Messenger; Telmisartan	2014
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer. Nanomedicine (London, England), 2016, Volume: 11, Issue:11 Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Coumarins; Docetaxel; Female; Heterografts; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Taxoids; Telmisartan; Thiazoles; Tumor Burden	2016
The Use of Telmisartan and the Incidence of Cancer. American journal of hypertension, 2016, 12-01, Volume: 29, Issue:12 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Breast Neoplasms; Colorectal Neoplasms; Databases, Factual; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Telmisartan; Time Factors; United Kingdom	2016